Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04468984 |
|---|---|
| Brief Title: | Study of Oral Navitoclax Tablet in Combination With Oral Ruxolitinib Tablet to Assess Change in Spleen Volume in Adult Participants With Relapsed/Refractory Myelofibrosis (TRANSFORM-2) |
| First Submitted : | July 10, 2020 |
| First Submitted that Met QC Criteria : | July 10, 2020 |
| First Posted : | July 13, 2020 |
| Last Update Submitted that Met QC Criteria : | April 2, 2024 |
| Last Update Posted : | April 4, 2024 |